Biofrontera starts patient recruitment for U.S. Phase III Trial Evaluating Ameluz® / BF-RhodoLED® for Superficial Basal Cell Carcinoma
September 26, 2018 03:15 ET
|
Biofrontera AG
Enrollment of 186 patients at 12 study sites in the U.S. startedPhase III trial completion for photodynamic therapy of superficial basal cell carcinoma expected in first half of 2020Filing for...
Photodynamic Therapy Fundamentals Presented
March 22, 2013 14:06 ET
|
American Society for Laser Medicine & Surgery, Inc. (ASLMS)
WAUSAU, Wis., March 22, 2013 (GLOBE NEWSWIRE) -- Laser 2013 will offer a session on Photodynamic Therapy, Friday, April 5, as part of the 33rd Annual Conference of the American Society for Laser...